{"organizations": [], "uuid": "4e7f1e408f1ff7d824ec584abc920e8cd5004374", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-china-resources-double-crane-pharm/brief-china-resources-double-crane-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PJ2GY", "country": "US", "domain_rank": 408, "title": "BRIEF-China Resources Double-crane Pharmaceutical unit receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.973, "site_type": "news", "published": "2018-01-24T14:23:00.000+02:00", "replies_count": 0, "uuid": "4e7f1e408f1ff7d824ec584abc920e8cd5004374"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-china-resources-double-crane-pharm/brief-china-resources-double-crane-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PJ2GY", "ord_in_thread": 0, "title": "BRIEF-China Resources Double-crane Pharmaceutical unit receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "china resources double-crane pharmaceutical co ltd", "sentiment": "negative"}, {"name": "henan food and drug administration", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd\n* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration\n* Certificate issued to edaravone manufactured by the unit and the valid period is until Jan. 7, 2023\nSource text in Chinese: goo.gl/2sR7k1\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/2sR7k1", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T14:23:00.000+02:00", "crawled": "2018-01-25T12:59:06.015+02:00", "highlightTitle": ""}